The Leadership Team at Byondis is responsible for steering the strategic direction and overall operations of the company. Comprised of top executives and principal scientists, the team ensures alignment between scientific innovation and business objectives. They drive initiatives to advance the company's precision medicine portfolio, oversee research and development, manage corporate development, and ensure legal and regulatory compliance, all to fulfill the company’s mission of providing novel, effective treatments for cancers and autoimmune diseases.
Aad van de Leur
COO
Deborah Hol-Schop
Principal Scientist USP
Fred Dijcks
Principal Scientist
Gerrit Voortman
Vice President Corporate Devel...
Marieke van Gent
Vice President Intellectual Pr...
Mark Eggink
Principal Scientist
Norbert Koper
Vice President Clinical Develo...
Patrick Groothuis
Principal Scientist, In Vivo P...
Willem-Jan Karstens
Principal Scientist
Wim Dokter
Chief Scientific Officer